surmount-1 tirzepatide weight loss results after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Analysis of Tirzepatide Acquisition Costs

Studies show spontaneous erections occur in up to 80% of users during the active window, with effects often persisting across multiple days from a single subcutaneous dose of 0.52mg

It contains a peptide that spurs weight loss by decreasing inflammation and increasing nitric oxide, which signals your body to optimize its metabolic rate for increased fat burning

95% CI: 0.450.71

Cheilosis is a common yet often overlooked condition that can cause significant discomfort if not managed properly

Common side effects of tirzepatide include gastrointestinal symptoms such as: Nausea Vomiting Constipation Diarrhea These side effects are usually mild to moderate and improve over time